Mar 27 |
Q4 2023 Acumen Pharmaceuticals Inc Earnings Call
|
Mar 26 |
Acumen Pharmaceuticals, Inc. (ABOS) Q4 2023 Earnings Call Transcript
|
Mar 26 |
Acumen Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation
|
Mar 26 |
Acumen Pharmaceuticals GAAP EPS of -$1.08
|
Mar 26 |
Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2023 and Business Highlights
|
Mar 21 |
Is Acumen Pharmaceuticals (ABOS) Outperforming Other Medical Stocks This Year?
|
Mar 21 |
Acumen Pharmaceuticals to Present Deeper Insights, Including Fluid Biomarker Data for Sabirnetug (ACU193), During Emerging Science Session at the American Academy of Neurology Annual Meeting
|
Mar 19 |
Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2023 Financial Results on March 26, 2024
|
Mar 18 |
15 Best Anti-Aging Foods for Youthful Skin
|
Mar 12 |
Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days
|